|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.26 EUR | +0.19% |
|
+2.95% | -20.68% |
| Dec. 11 | Analysts skeptical about chemical stocks for 2026 – shares recover | DP |
| Dec. 10 | Germany's VCI expects chemical industry to stagnate in 2026 | RE |
| Capitalization | 6.17B 7.25B 5.77B 5.43B 9.99B 656B 10.91B 67.32B 26.11B 309B 27.2B 26.62B 1,129B | P/E ratio 2025 * |
16.9x | P/E ratio 2026 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise value | 9.45B 11.09B 8.83B 8.31B 15.29B 1,005B 16.71B 103B 39.97B 474B 41.63B 40.75B 1,728B | EV / Sales 2025 * |
0.68x | EV / Sales 2026 * | 0.67x |
| Free-Float |
53.47% | Yield 2025 * |
8.83% | Yield 2026 * | 8.83% |
Last Transcript: Evonik Industries AG
| 1 day | +0.34% | ||
| 1 week | +2.87% | ||
| Current month | -0.08% | ||
| 1 month | -0.75% | ||
| 3 months | -17.23% | ||
| 6 months | -29.51% | ||
| Current year | -20.74% |
| 1 week | 12.8 | 13.36 | |
| 1 month | 12.71 | 13.81 | |
| Current year | 12.71 | 22.39 | |
| 1 year | 12.71 | 22.39 | |
| 3 years | 12.71 | 22.39 | |
| 5 years | 12.71 | 31 | |
| 10 years | 12.71 | 32.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2017-05-23 | |
Tim Lange
IRC | Investor Relations Contact | - | 2011-10-31 |
Anke Dassler
AUD | Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Rüdiger
BRD | Director/Board Member | 61 | 2013-03-10 |
| Director/Board Member | 59 | 2014-06-30 | |
Martin Albers
BRD | Director/Board Member | 59 | 2015-09-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.34% | +2.87% | -22.21% | -25.38% | 7.25B | ||
| +0.87% | +1.51% | +5.36% | +75.22% | 74.66B | ||
| +2.35% | -5.06% | -22.30% | +5.80% | 35.61B | ||
| +1.66% | +2.59% | -28.32% | -29.78% | 32.21B | ||
| +0.46% | +6.19% | +1.93% | +44.10% | 26.81B | ||
| +1.25% | +7.46% | +74.29% | -26.83% | 18.8B | ||
| -0.96% | -0.34% | +52.08% | +127.80% | 16.71B | ||
| +1.41% | +3.82% | -10.02% | -12.42% | 16.12B | ||
| -1.37% | +6.03% | +33.57% | -46.45% | 15.62B | ||
| -0.23% | +7.52% | +32.79% | +14.47% | 13.33B | ||
| Average | +0.58% | +1.75% | +11.72% | +12.65% | 25.71B | |
| Weighted average by Cap. | +0.86% | +1.06% | +6.42% | +26.29% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 13.99B 16.42B 13.07B 12.29B 22.63B 1,487B 24.73B 153B 59.16B 701B 61.61B 60.31B 2,558B | 14.02B 16.45B 13.09B 12.32B 22.68B 1,490B 24.77B 153B 59.27B 702B 61.73B 60.43B 2,563B |
| Net income | 365M 428M 341M 321M 590M 38.78B 645M 3.98B 1.54B 18.28B 1.61B 1.57B 66.7B | 451M 529M 421M 396M 729M 47.91B 797M 4.91B 1.91B 22.58B 1.98B 1.94B 82.4B |
| Net Debt | 3.28B 3.85B 3.06B 2.88B 5.3B 348B 5.79B 35.73B 13.86B 164B 14.43B 14.13B 599B | 3.24B 3.81B 3.03B 2.85B 5.25B 345B 5.73B 35.36B 13.72B 163B 14.28B 13.98B 593B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-15 | 13.27 € | +0.30% | 189,384 |
| 25-12-12 | 13.25 € | -0.08% | 826,541 |
| 25-12-11 | 13.26 € | +3.35% | 1,513,991 |
| 25-12-10 | 12.83 € | -0.77% | 875,821 |
| 25-12-09 | 12.93 € | +0.31% | 954,930 |
Delayed Quote Xetra, December 15, 2025 at 06:30 am EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EVK Stock
Select your edition
All financial news and data tailored to specific country editions
















